Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-04
2007-12-04
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000, C544S111000, C544S133000, C544S135000, C548S146000, C548S152000, C548S161000, C514S231200, C514S233500, C514S365000, C514S367000
Reexamination Certificate
active
10848436
ABSTRACT:
The present invention relates to a compound of formula Iwherein R, X and n are defined hereinabove, and to a pharmaceutically acceptable salt thereof. The compound may be used for the treatment of diseases related to the A2A receptor.
REFERENCES:
patent: 6521754 (2003-02-01), Alanine et al.
patent: 6734179 (2004-05-01), Flohr et al.
patent: 6835732 (2004-12-01), Alanine et al.
patent: 6963000 (2005-11-01), Alanine et al.
patent: WO 01/97786 (2001-12-01), None
patent: WO 03/053946 (2003-07-01), None
Alanine et al (2001): STN International HCAPLUS database, Columbus (Ohio), accession No. 2001:935384.
Flohr Alexander
Jakob-Roetne Roland
Norcross Roger David
Riemer Claus
Hoffmann-La Roche Inc.
Johnston George J.
Rocha-Tramaloni Patricia S.
Yao Gene J.
LandOfFree
Carbamic acid esters of benzothiazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamic acid esters of benzothiazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamic acid esters of benzothiazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3882034